Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Nektar Therapeutics buy BiotechBee

Nektar Therapeutics
Start price
€60.20
04:40 / 70%
Target price
€110.00
31.07.28
Performance (%)
-0.03%
Price
€59.90
15:47
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Nektar Therapeutics is nearly unchanged. This prediction currently runs until 31.07.28. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w
Nektar Therapeutics -0.03%
iShares Core DAX® 2.591%
iShares Nasdaq 100 -0.915%
iShares Nikkei 225® 0.145%
iShares S&P 500 -0.367%

According to BiotechBee what are the pros and cons of Nektar Therapeutics for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Nektar Therapeutics diskutieren
Prediction Buy
Perf. (%) -0.03%
Target price 110.000
Change
Ends at 31.07.28

Buy mit Kursziel 110,0

BiotechBee 
0
Report Share
04:40

Stopped prediction by BiotechBee for Nektar Therapeutics

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€40.80
14.09.25
€100.00
28.11.27
-0.49%
15.09.25

Could be very worthwhile Investment >20% year
BiotechBee 
14.09.25 70%